XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Directors
Employees
Total Share holders’ Equity
Total Share holders’ Equity
Directors
Total Share holders’ Equity
Employees
Common Stock
Common Stock
Directors
Common Stock
Employees
Capital in Excess of Par Value
Capital in Excess of Par Value
Directors
Capital in Excess of Par Value
Employees
Retained Earnings
Accumulated Other Comp- rehensive Income (loss), net
Non- Controlling Interest
Beginning balance (shares) at Dec. 31, 2022             18,919,372                
Beginning balance at Dec. 31, 2022 $ 444,211     $ 407,145     $ 1,892     $ 64,212     $ 342,317 $ (1,276) $ 37,066
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Exercise of stock options (shares)             35,470                
Exercise of stock options 803     803     $ 4     799          
Stock option grant compensation 33     33           33          
Restricted stock compensation 518     518           518          
Shares granted to Employees and Directors (shares)               20,760 1,856            
Shares granted to Employees and Directors   $ 600 $ 50   $ 600 $ 50   $ 2     $ 598 $ 50      
Restricted stock award (shares)             50,568                
Restricted stock award 0           $ 4     (4)          
Shares purchased and cancelled (shares)             (36,680)                
Shares purchased and cancelled (1,000)     (1,000)     $ (2)     (128)     (870)    
Net income 898     1,163                 1,163   (265)
Distributions to partners (1,685)                           (1,685)
Minimum pension liability,net (16)     (16)                   (16)  
Unrealized loss on investment, net 580     580                   580  
Ending balance at Jun. 30, 2023 444,992     409,876     $ 1,900     66,078     342,610 (712) 35,116
Ending balance (shares) at Jun. 30, 2023             18,991,346                
Beginning balance (shares) at Mar. 31, 2023             19,007,266                
Beginning balance at Mar. 31, 2023 445,185     409,211     $ 1,900     65,331     342,882 (902) 35,974
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock option grant compensation 16     16           16          
Restricted stock compensation 261     261           261          
Shares granted to Employees and Directors (shares)               20,760              
Shares granted to Employees and Directors   600     600     $ 2     598        
Shares purchased and cancelled (shares)             (36,680)                
Shares purchased and cancelled (1,000)     (1,000)     $ (2)     (128)     (870)    
Net income 492     598                 598   (106)
Distributions to partners (752)                           (752)
Minimum pension liability,net (16)     (16)                   (16)  
Unrealized loss on investment, net 206     206                   206  
Ending balance at Jun. 30, 2023 $ 444,992     409,876     $ 1,900     66,078     342,610 (712) 35,116
Ending balance (shares) at Jun. 30, 2023             18,991,346                
Beginning balance (shares) at Dec. 31, 2023 18,968,448           18,968,448                
Beginning balance at Dec. 31, 2023 $ 447,976     414,520     $ 1,897     66,706     345,882 35 33,456
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock option grant compensation 39     39           39          
Restricted stock compensation 641     641           641          
Shares granted to Employees and Directors (shares)               19,356              
Shares granted to Employees and Directors   $ 600     $ 600     $ 2     $ 598        
Restricted stock award (shares)             42,670                
Restricted stock award 0           $ 4     (4)          
Net income 3,394     3,345                 3,345   49
Distributions to partners (1,489)                           (1,489)
Minimum pension liability,net (15)     (15)                   (15)  
Unrealized loss on investment, net 2     2                   2  
Ending balance at Jun. 30, 2024 $ 451,148     419,132     $ 1,903     67,980     349,227 22 32,016
Ending balance (shares) at Jun. 30, 2024 19,030,474           19,030,474                
Beginning balance (shares) at Mar. 31, 2024             19,000,600                
Beginning balance at Mar. 31, 2024 $ 448,871     416,133     $ 1,900     67,023     347,183 27 32,738
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock option grant compensation 20     20           20          
Restricted stock compensation 340     340           340          
Shares granted to Employees and Directors (shares)             19,356                
Shares granted to Employees and Directors 600     600     $ 2     598          
Restricted stock award (shares)             10,518                
Restricted stock award 0           $ 1     (1)          
Net income 2,059     2,044                 2,044   15
Distributions to partners (737)                           (737)
Minimum pension liability,net (7)     (7)                   (7)  
Unrealized loss on investment, net 2     2                   2  
Ending balance at Jun. 30, 2024 $ 451,148     $ 419,132     $ 1,903     $ 67,980     $ 349,227 $ 22 $ 32,016
Ending balance (shares) at Jun. 30, 2024 19,030,474           19,030,474